Please assess the completion status of the following clinical trial:

Trial Title: Omega-3 and Therapy Study for Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. aged 7-14 years (boys and girls)~2. DSM-IV-TR diagnosis of major depressive disorder and/or dysthymic disorder as determined by consensus conference~3. Children's Depression Rating Scale (CDRS-R) score ≥ 40~4. full scale IQ ≥ 70~5. child and at least one parent must be able to complete all assessments~6. child must be able to swallow capsules (training in swallowing will be offered)~7. parent/guardian and child must be willing to have blood drawn from child at two study assessments.~Exclusion Criteria:~1. major medical disorders (eg diabetes, epilepsy, metabolic disorder)~2. inability to communicate in English~3. lack of access via phone~4. autism~5. schizophrenia, or other psychotic states warranting anti-psychotic medication~6. DSM-IV-TR diagnosis of a bipolar disorder~7. active suicidal concern (e.g., I want to kill myself, a plan for suicide, or an attempt in the past month; however, passive suicidal ideation, such as I wish I were dead would not exclude)~8. intake in the previous 4 weeks of supplemental Ω3 fatty acids.

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 14 Years
- Healthy Volunteers: f

Study Arms:
- Placebo Supplement and No PEP (Type: PLACEBO_COMPARATOR): Will receive two capsules by mouth, two times daily matched for odor and appearance with the active intervention.
- Omega-3 and PEP (Type: EXPERIMENTAL): Omega-3 Supplementation will receive 1000 mg Ω3 (two 500 mg capsules, each containing 350 mg EPA: 50 mg DHA; 100 other Ω3)by mouth, two times daily.~Psychoeducational Psychotherapy (PEP)Therapy sessions occur twice a week for up to 24 sessions of manualized treatment.
- Omega-3 and No PEP (Type: EXPERIMENTAL): Omega-3 Supplementation will receive 1000 mg Ω3 (two 500 mg capsules, each containing 350 mg EPA: 50 mg DHA; 100 other Ω3)by mouth, two times daily.
- Placebo Supplement and PEP (Type: EXPERIMENTAL): Placebo Supplement will receive two capsules by mouth, two times daily matched for odor and appearance with the active intervention.~Psychoeducational Psychotherapy (PEP)Therapy sessions occur twice a week for up to 24 sessions of manualized treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).